<?xml version="1.0" encoding="UTF-8" ?>

    <journal>
    <language>en</language>
    <journal_id_issn>2008-2835</journal_id_issn>
    <journal_id_issn_online>2008-4625</journal_id_issn_online>
    <journal_id_pii></journal_id_pii>
    <journal_id_doi></journal_id_doi>
    <journal_id_isnet></journal_id_isnet>
    <journal_id_iranmedex>276</journal_id_iranmedex>
    <journal_id_magiran>5669</journal_id_magiran>
    <journal_id_sid>11181</journal_id_sid>
    <pubdate>
	    <type>gregorian</type>
	    <year>>2016</year>
	    <month>>April-June</month>
	    <day></day>
    </pubdate>
    <volume>8</volume>
    <number>2</number>
    <publish_type>online</publish_type>
    <publish_edition>1</publish_edition>
    <article_type>fulltext</article_type>
    <articleset>

<article>
	<language>en</language>
	<article_id_issn></article_id_issn>
	<article_id_issn_online></article_id_issn_online>
	<article_id_pubmed>27141268</article_id_pubmed>
	<article_id_pii></article_id_pii>
	<article_id_doi></article_id_doi>
	<article_id_iranmedex></article_id_iranmedex>
	<article_id_magiran></article_id_magiran>
	<article_id_sid></article_id_sid>
	<title_fa></title_fa>
	<title>LC-MS Method for Studying the Pharmacokinetics and Bioequivalence of Clonidine Hydrochloride in Healthy Male Volunteers</title>
	<subject_fa></subject_fa>
	<subject></subject>
	<content_type_fa></content_type_fa>
	<content_type></content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;p&gt;Background: A simple and sensitive high performance liquid chromatography-electrospray ionization mass spectrometry method has been evaluated for the assignment of clonidine hydrochloride in human plasma.&lt;br /&gt;
Methods: The mobile phase composed of acetonitrile-water 60:40 (&lt;em&gt;v/v&lt;/em&gt;) and 0.2% formic acid 20&lt;em&gt; &amp;micro;l&lt;/em&gt; of sample was chromatographically analyzed using a repacked ZORBAX-XDB-ODS C&lt;sub&gt;18&lt;/sub&gt; column (2.1 &lt;em&gt;mm&lt;/em&gt;x30 &lt;em&gt;mm&lt;/em&gt;, 3.5 &lt;em&gt;&amp;mu;&lt;/em&gt;). Detection of analytes was achieved by tandem mass spectrometry with Electrospray Ionization (ESI) interface in positive ion mode operated under the multiple-reaction monitoring mode (m/z 230.0 &amp;rarr;213). Sample pretreatment consisted of a one-step Protein Precipitation (PPT) with methanol and perchloric acid (HClO&lt;sub&gt;4&lt;/sub&gt;) of 0.10 &lt;em&gt;ml&lt;/em&gt; plasma.&lt;br /&gt;
Results: Standard curve was linear (r=0.998) over the concentration range of 0.01-10.0 &lt;em&gt;ng/ml&lt;/em&gt; and showed suitable accuracy and precision. The Limit of Quantification (LOQ) was 0.01 &lt;em&gt;ng/ml&lt;/em&gt;. The mean (SD) Cmax, Tmax, AUC&lt;sub&gt;0&amp;ndash;t &lt;/sub&gt;and AUC&lt;sub&gt;0&amp;ndash;&amp;infin;&lt;/sub&gt; values after administration of the test and reference formulations, respectively, were in this manner: 6.16 (0.32) versus 6.21 (0.07) &lt;em&gt;ng/ml&lt;/em&gt;, 30.12 (0.86) versus 30.13 (0.73) &lt;em&gt;hr&lt;/em&gt;, 290.37 (1.13) versus 293.39 (1.22) &lt;em&gt;ng/ml/hr&lt;/em&gt;, and 350.17 (1.98) versus 352.96 (1.67) &lt;em&gt;ng/ml/hr&lt;/em&gt;. The mean (SD) t1/2 was 120.12 (1.90) &lt;em&gt;hr&lt;/em&gt; for the test formulation and 120.96 (1.54) hr for the reference formulation. No statistical differences were showed for Cmax and the area under the plasma concentration-time curve for test and reference tablets.&lt;br /&gt;
Conclusion: The method is rapid, simple, very steady and precise for the separation, assignment, pharmacokinetic and bioavailability evaluation of clonidine in healthy Iranian adult male volunteers.&lt;/p&gt;
</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Clonidine hydrochloride, High performance liquid chromatography, Pharmacokinetics</keyword>
	<start_page>91</start_page>
	<end_page>98</end_page>
	<web_url>https://www.ajmb.org/En/Article.aspx?id=239</web_url>
    <pdf_url>https://www.ajmb.org/PDF/En/FullText/239.pdf</pdf_url>
	<author_list><author><first_name>Hossein</first_name><middle_name></middle_name><last_name>Danafar</last_name><suffix></suffix><affiliation>Department of Medicinal Chemistry, Faculty of Pharmacy, Zanjan University of Medical Sciences, Zanjan, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>991</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author><author><first_name>Mehrdad</first_name><middle_name></middle_name><last_name>Hamidi</last_name><suffix></suffix><affiliation>Department of Pharmaceutics, Faculty of Pharmacy, Zanjan University of Medical Sciences, Zanjan, Iran</affiliation><first_name_fa></first_name_fa><middle_name_fa></middle_name_fa><last_name_fa></last_name_fa><suffix_fa></suffix_fa><email></email><code>992</code><coreauthor></coreauthor><affiliation_fa></affiliation_fa></author></author_list>
</article>

</articleset>
</journal>

